Showing results (91-100 of 328) with videos related to
Sort By:
Pageof 33
Molecular Therapy. Nucleic Acids|July 20, 2016
CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV VectorGiridhar Murlidharan, Kensuke Sakamoto, Lavanya Rao, et al.The Journal of Clinical Investigation|January 4, 2021
Overcoming innate immune barriers that impede AAV gene therapy vectorsManish Muhuri, Yukiko Maeda, Hong Ma, et al.Molecular Therapy. Methods & Clinical Development|November 9, 2018
<i>MicroRNA-96</i> Promotes Schistosomiasis Hepatic Fibrosis in Mice by Suppressing <i>Smad7</i>Xufeng Luo, Dongmei Zhang, Jun Xie, et al.Gene Therapy|August 12, 2024
The AAV2.7m8 capsid packages a higher degree of heterogeneous vector genomes than AAV2Mengtian Cui, Qin Su, Mitchell Yip, et al.Human Gene Therapy|May 11, 2019
High-Throughput Quantification of <i>In Vivo</i> Adeno-Associated Virus Transduction with Barcoded Non-Coding RNAsMeiyu Xu, Jia Li, Jun Xie, et al.Nature Communications|January 31, 2018
Streamlined ex vivo and in vivo genome editing in mouse embryos using recombinant adeno-associated virusesYeonsoo Yoon, Dan Wang, Phillip W L Tai, et al.Pathology, Research and Practice|May 16, 2025
Single-cell transcriptomic analyses provide insights into the tumor microenvironment heterogeneity and invasion phenotype in retinoblastomaXiaoliang Zhang, Hong Liu, Zhida Lan, et al.Molecular Therapy. Nucleic Acids|January 23, 2024
AAV-based gene editing of type 1 collagen mutation to treat osteogenesis imperfectaYeon-Suk Yang, Tadatoshi Sato, Sachin Chaugule, et al.Nucleic Acids Research|March 29, 2025
A deep learning model trained on expressed transcripts across different tissue types reveals cell-type codon-optimization preferencesSandhiya Ravi, Tapan Sharma, Mitchell Yip, et al.Journal of Virology|July 15, 2006
A common mechanism for cytoplasmic dynein-dependent microtubule binding shared among adeno-associated virus and adenovirus serotypesSamir Kelkar, Bishnu P De, Guangping Gao, et al.Pageof 33